Literature DB >> 20872569

The activity of class I, II, III, and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in endometrial cancer.

Karolina Orywal1, Wojciech Jelski, Michał Zdrodowski, Maciej Szmitkowski.   

Abstract

OBJECTIVE: The metabolism of cancerous cells is in many ways different than in healthy cells. In endometrial cancer, cells exhibit activity of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), which participate in the metabolism of many biological substances. The aim of this study was to compare the metabolism of endometrial cancer cells and normal endometrial cells by measurement of ADH isoenzymes and ALDH activities in these tissues.
METHODS: The study material consists of cancerous endometrial tissues obtained from 34 patients. Total ADH activity was measured using the photometric method and ALDH activity using the fluorometric method. For the measurement of class I and II ADH isoenzyme activity, we employed the fluorometric method, with class-specific fluorogenic substrates. The activity of class III and IV ADH was measured using the photometric method.
RESULTS: The activity of the class I ADH isoenzyme was significantly higher in the endometrial cancer tissues when compared with normal endometrial tissues. The other classes of ADH tested did not show significant differences between activity of cancerous cells and healthy endometrium. The activity of total ADH was also significantly higher in endometrial cancer.
CONCLUSION: The increased activity of total ADH in endometrial cancer, especially the class I isoenzyme and normal activity of ALDH, may be the cause of disorders in metabolic pathways that use these isoenzymes and could increase the concentration of acetaldehyde, which is cancerogenic substance. J. Clin. Lab. Anal. 24:334-339, 2010.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872569      PMCID: PMC6647728          DOI: 10.1002/jcla.20412

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

1.  Reduced risk of endometrial cancer from alcohol drinking in Japanese.

Authors:  Satoyo Hosono; Keitaro Matsuo; Hiroaki Kajiyama; Kaoru Hirose; Takeshi Suzuki; Akio Hiraki; Takakazu Kawase; Kumiko Kidokoro; Toru Nakanishi; Nobuyuki Hamajima; Fumitaka Kikkawa; Kazuo Tajima; Hideo Tanaka
Journal:  Cancer Sci       Date:  2008-04-14       Impact factor: 6.716

2.  Ethnic differences in gastric sigma-alcohol dehydrogenase activity and ethanol first-pass metabolism.

Authors:  K Dohmen; E Baraona; H Ishibashi; G Pozzato; M Moretti; C Matsunaga; K Fujimoto; C S Lieber
Journal:  Alcohol Clin Exp Res       Date:  1996-12       Impact factor: 3.455

3.  Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase.

Authors:  M Koivusalo; M Baumann; L Uotila
Journal:  FEBS Lett       Date:  1989-10-23       Impact factor: 4.124

4.  Alcohol consumption and endometrial cancer risk: the multiethnic cohort.

Authors:  Veronica Wendy Setiawan; Kristine R Monroe; Marc T Goodman; Laurence N Kolonel; Malcolm C Pike; Brian E Henderson
Journal:  Int J Cancer       Date:  2008-02-01       Impact factor: 7.396

5.  Identification of an acetaldehyde adduct in human liver DNA and quantitation as N2-ethyldeoxyguanosine.

Authors:  Mingyao Wang; Nanxiong Yu; Li Chen; Peter W Villalta; J Bradley Hochalter; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2006-02       Impact factor: 3.739

Review 6.  Endometrial cancer.

Authors:  Joel I Sorosky
Journal:  Obstet Gynecol       Date:  2008-02       Impact factor: 7.661

7.  The activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in esophageal cancer.

Authors:  Wojciech Jelski; Miroslaw Kozlowski; Jerzy Laudanski; Jacek Niklinski; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2008-08-09       Impact factor: 3.199

8.  Estradiol regulates class I alcohol dehydrogenase gene expression in renal medulla of male rats by a post-transcriptional mechanism.

Authors:  M Qulali; D W Crabb
Journal:  Arch Biochem Biophys       Date:  1992-09       Impact factor: 4.013

9.  Alcohol consumption and postmenopausal endometrial cancer: results from the Iowa Women's Health Study.

Authors:  S M Gapstur; J D Potter; T A Sellers; L H Kushi; A R Folsom
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

10.  The activity of class I, II, III and IV of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the wall of abdominal aortic aneurysms.

Authors:  Wojciech Jelski; Karolina Orywal; Bogusław Panek; Marek Gacko; Barbara Mroczko; Maciej Szmitkowski
Journal:  Exp Mol Pathol       Date:  2009-03-28       Impact factor: 3.362

View more
  5 in total

Review 1.  The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation.

Authors:  Li Di; Amanda Balesano; Samantha Jordan; Sophia M Shi
Journal:  AAPS J       Date:  2021-01-07       Impact factor: 4.009

2.  Enhanced catabolism to acetaldehyde in rostral ventrolateral medullary neurons accounts for the pressor effect of ethanol in spontaneously hypertensive rats.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-09       Impact factor: 4.733

Review 3.  Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms.

Authors:  Karolina Orywal; Maciej Szmitkowski
Journal:  Clin Exp Med       Date:  2016-02-17       Impact factor: 3.984

4.  Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma.

Authors:  Xiwen Liao; Rui Huang; Xiaoguang Liu; Chuangye Han; Long Yu; Shijun Wang; Na Sun; Bopei Li; Xin Ning; Tao Peng
Journal:  Onco Targets Ther       Date:  2017-07-24       Impact factor: 4.147

5.  Prognostic value of alcohol dehydrogenase mRNA expression in gastric cancer.

Authors:  Erna Guo; Haotang Wei; Xiwen Liao; Yang Xu; Shu Li; Xiaoyun Zeng
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.